According to this article on ClinicalTrialsToday, participation from investors in global clinical trials conducted in the Central and Eastern European region was up 25% over the prior year’s. A reason why this is happening is because there has been a slight change in setting up investigator meetings.
One aspect is that meetings should be set in “nice” locations outside of Eastern Europe. Investigators from Eastern Europe like to travel and so that would produce higher numbers. Also, give the investigators some time for sightseeing as they rarely step foot outside of the office. This will take away the bitter feelings of having to sit within four walls and then return home immediately. Take a look at the article to see the rest of the aspects highlighted.
Wednesday, December 17, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment